RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Pharma-Bio Serv - Stock

Pharma-Bio Serv Stocks 2024

Pharma-Bio Serv Stocks

23 M

Ticker

PBSV

ISIN

US71711N1000

In 2024, Pharma-Bio Serv had 23 M outstanding stocks, a 0% change from the 23 M stocks in the previous year.

The Pharma-Bio Serv Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2025e23
2024e23
202323
202223.03
202123.03
202023.04
201923.11
201823.1
201723.1
201623.02
201523.4
201423.69
201323.66
201222.94
201122.55
201022.38
200922.33
200822.26
200722.17
200617.88
20050.27

Pharma-Bio Serv shares outstanding

The number of shares was Pharma-Bio Serv in 2023 — This indicates how many shares 22.998 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Pharma-Bio Serv earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Pharma-Bio Serv's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Pharma-Bio Serv’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Pharma-Bio Serv's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Pharma-Bio Serv Aktienanalyse

What does Pharma-Bio Serv do?

Pharma-Bio Serv Inc is an international company based in Puerto Rico that was founded in 1993. The company offers a wide range of high-quality services to the pharmaceutical, biotech, and hospital industries and has become a leading service provider in this field. Pharma-Bio Serv ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Pharma-Bio Serv's Shares Outstanding

Pharma-Bio Serv's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Pharma-Bio Serv’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Pharma-Bio Serv’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Pharma-Bio Serv’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Pharma-Bio Serv Stock

How many stocks are there of Pharma-Bio Serv?

The current number of stocks of Pharma-Bio Serv is 23 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Pharma-Bio Serv are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Pharma-Bio Serv evolved in recent years?

The number of shares of Pharma-Bio Serv has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Pharma-Bio Serv as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Pharma-Bio Serv?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Pharma-Bio Serv pay?

Over the past 12 months, Pharma-Bio Serv paid a dividend of 0.15 USD . This corresponds to a dividend yield of about 24.83 %. For the coming 12 months, Pharma-Bio Serv is expected to pay a dividend of 0.15 USD.

What is the dividend yield of Pharma-Bio Serv?

The current dividend yield of Pharma-Bio Serv is 24.83 %.

When does Pharma-Bio Serv pay dividends?

Pharma-Bio Serv pays a quarterly dividend. This is distributed in the months of January, March, April, February.

How secure is the dividend of Pharma-Bio Serv?

Pharma-Bio Serv paid dividends every year for the past 5 years.

What is the dividend of Pharma-Bio Serv?

For the upcoming 12 months, dividends amounting to 0.15 USD are expected. This corresponds to a dividend yield of 24.13 %.

In which sector is Pharma-Bio Serv located?

Pharma-Bio Serv is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pharma-Bio Serv kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pharma-Bio Serv from 2/15/2024 amounting to 0.075 USD, you needed to have the stock in your portfolio before the ex-date on 1/29/2024.

When did Pharma-Bio Serv pay the last dividend?

The last dividend was paid out on 2/15/2024.

What was the dividend of Pharma-Bio Serv in the year 2023?

In the year 2023, Pharma-Bio Serv distributed 0.075 USD as dividends.

In which currency does Pharma-Bio Serv pay out the dividend?

The dividends of Pharma-Bio Serv are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Pharma-Bio Serv

Our stock analysis for Pharma-Bio Serv Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pharma-Bio Serv Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.